Mitchell Paul Levesque

59PUBLICATIONS
397CO-AUTHORS
Predictive and prognostic markersInnate immunityGene and molecular therapyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jul 13, 2026
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

|May 29, 2026
NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis.

|May 26, 2026
NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation.

|Mar 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Feb 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Benedict Gosztonyi, Tarun Mehra, Gabriele Gut

|Dec 12, 2025
Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

Pageof 10

Frequent Collaborators

23 joint publications

Reinhard Dummer

11 joint publications

Phil Fang Cheng

11 joint publications

Patrick Turko

8 joint publications

Egle Ramelyte